Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer [WNT_INH]

ABSTRACT: We used RNA-Seq to profile APCmin, KRASG12D, TP53 murine organoids in the presence and absence of EGFR in combination with control or 2 µM ICG-001 or 3 µM CHIR99021 treatment.

ORGANISM(S): Mus musculus

PROVIDER: GSE289571 | GEO | 2025/03/04

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer [BPTES]

Project description:We used RNA-Seq to profile APCmin, KRASG12D, TP53 murine organoids in the presence and absence of EGFR in combination with control or 10 µM BPTES treatment.

2025-03-04 | GSE289570 | GEO

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer

Project description:We used RNA-Seq to profile APCmin, KRASG12D, TP53 murine organoids in the presence and absence of EGFR.

2025-03-04 | GSE263594 | GEO

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer [scRNA]

Project description:We used scRNA-Seq to profile APCmin, KRASG12D, TP53 murine organoids in the presence and absence of EGFR.

2025-03-04 | GSE289737 | GEO

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer [SMOC2]

Project description:We used RNA-Seq to profile APCmin, KRASG12D, TP53 murine organoids in the presence and absence of EGFR and additional deletion of SMOC2.

2025-03-04 | GSE289455 | GEO

EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer [MRTX1133]

Project description:We used RNA-Seq to profile APCmin, KRASG12D, TP53 murine organoids in the presence and absence of EGFR in combination with control or MRTX1133 (100 nM) treatment.

2025-03-04 | GSE289498 | GEO

Targeting WNT Signaling for Improved Glioma Immunotherapy [PBT]

Project description:Metabolic gene expression analysis to explore ICG-001’s impact on metabolic changes associated with glioma differentiation after disrupting the CBP/β-Catenin interaction by treating patient-derived GBM cell lines PBT147 and PBT030 with ICG-001 (0, 5, or 10 µM) for 24 and 72 h using Nanostring nCounter platform

2024-02-15 | GSE252155 | GEO

Targeting WNT Signaling for Improved Glioma Immunotherapy [IL13R?2-targeted CAR T cells]

2024-12-20 | GSE251930 | GEO

Regulation of gene expression in uveal melanoma cells by ICG-001

Project description:We examined the effects of ICG-001 on gene expression in Mel202 uveal melanoma (UM) cells. ICG-001 exerted strong antiproliferative activity against UM cells, leading to cell cycle arrest, apoptosis, and inhibition of migration. Global gene expression profiling revealed strong suppression of genes associated with cell cycle proliferation, DNA replication, and G1/S transition. Gene set enrichment analysis revealed that ICG-001 suppressed Wnt, mTOR, and MAPK signaling. Strikingly, ICG-001 suppressed the expression of genes associated with UM aggressiveness, including CDH1, CITED1, EMP1, EMP3, SDCBP, and SPARC. Notably, the transcriptomic footprint of ICG-001, when applied to a UM patient dataset, was associated with better clinical outcome. Lastly, ICG-001 exerted anticancer activity against a UM tumor xenograft in mice.

2020-04-28 | GSE149417 | GEO

ICG-001 activates a series of ER stress response genes in monocyte derived macrophages (MDMs)

Project description:By screening a target-focused Wnt-sgnaling small compound library we identified the Wnt-modulator ICG-001 as inihibitory for activating the mitochondrial fission protein Drp1. To explore how ICG-001 might act we undertook gene expression profiling in iCG-001 treated primary macrophages.

2018-01-12 | GSE102117 | GEO

The Î²-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner

Project description:In pediatric glioma cell lines, treatment with ICG-001 had no inhibitory effect on canonical Wnt-target genes but induced significant up regulation of various known Î²-catenin target genes in both cell lines and top 20 GO-annotations of down-regulated genes by ICG-001 were associated with biosynthetic and metabolic processes and cell cycle division processes. Pediatric cell lines were treated with ICG-001 or DMSO for 48h

2016-06-14 | E-GEOD-83266 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data